Impact of an Integral Assistance on the Management of Patients with Chronic Heart Diseases

Login or register to view PDF.
Received date
14 December 2017
Accepted date
14 December 2017
Citation
European Cardiology Review 2017;12(2):97.
DOI
https://doi.org/10.15420/ecr.2017:23:6

Best Poster Award
Topic: 1. Clinical Cardiology

 

Introduction and Objectives

Conventional care model between cardiology and primary care has many limitations (i.e. inadequate communication and coordination between healthcare levels). A change in healthcare model is mandatory. The objective of this study is to analyze the impact of implementing a program integrating cardiology and primary care in clinical practice.

Materials and Methods

In the integrated care model, every cardiologist was integrated in each specific primary care center, attending patients weekly, participating in the discussion of clinical cases, virtual visits and ongoing medical education. In this observational study, number of visits and delay to cardiologist consultation were determined. LDL-cholesterol control rates in patients with ischemic heart disease and antithrombotic therapy in patients with atrial fibrillation (AF) were also studied. The new model was progressively implemented since December 2013.

Results

The implementation of the new care model was associated with a significant reduction of 31.2 % (p<0.05) in the request of the first visits. In addition, the delay to the cardiologist consultation significantly decreased in 55 days (54.5 %) for the first visits, and 112 days (57.1 %) for the follow-up visits (p<0.05). Between 2013 and 2016 the proportion of patients that achieved recommended LDL-cholesterol goals significantly increased from 20.8 % to 29.6 %, respectively (OR 1.61; 95 % CI 1.47-1.75). The proportion of anticoagulated patients significantly increased from 62.2 % to 72.8 % (p<0.05), respectively. Among anticoagulated patients, the proportion of patients taking direct oral anticoagulants significantly increased from 7.7 % in 2013 to 27.2 % in 2016 (p<0.05).

Conclusions

Implementing an integrated care model is feasible, reduces the number of visits, the delay to cardiologist consultation and improves surrogate variables, such as LDL cholesterol control rates and the proportion of AF patients receiving anticoagulation.

References
  1. Falces C, Andrea R, Heras M, Vehí C, Sorribes M, Sanchis L, et al. Integration between cardiology and primary care: impact on clinical practice. Rev Esp Cardiol. 2011;64:564-71.
    Crossref | PubMed
  2. Cook RI, Render M, Woods DD. Gaps in the continuity of care and progress on patient safety. BMJ. 2000;320:791-4.
    Crossref | PubMed
  3. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003;327:1219-21.
    Crossref | PubMed
  4. Comín-Colet J, Verdú-Rotellar JM, Vela E, Clèries M, Bustins M, Mendoza L, et al. Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. Rev Esp Cardiol (Engl Ed). 2014;67:283-93.
    Crossref | PubMed
  5. Díaz Sánchez S, Lobos Bejarano JM, Gonzalez-Juanatey JR. Atrial fibrillation: from detection to treatment. Role of the family physician, cardiologist and other specialists. New models of clinical management. Aten Primaria. 2013;45Suppl 1:18-29.
    Crossref | PubMed
  6. Penm J, MacKinnon NJ, Strakowski SM, Ying J, Doty MM. Minding the Gap: Factors Associated With Primary Care Coordination of Adults in 11 Countries. Ann Fam Med. 2017;15:113-119.
    Crossref | PubMed
  7. Hernández-Afonso J, Facenda-Lorenzo M, Rodríguez-Esteban M, Hernández-García C, Núñez-Chicharro L, Viñas-Pérez AD. New Model of Integration Between Primary Health Care and Specialized Cardiology Care. Rev Esp Cardiol (Engl Ed). 2017 Feb 28. [Epub ahead of print]
  8. Barrios V, Escobar C, Calderón A, Rodríguez Roca GC, Llisterri JL, Polo García J. Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care. Rev Esp Cardiol (Engl Ed). 2014;67:150-1.
    Crossref | PubMed
  9. Barrios V, Escobar C, Prieto L, Osorio G, Polo J, Lobos JM, et al.Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study. Rev Esp Cardiol (Engl Ed). 2015;68:769-76.
    Crossref | PubMed
  10. Martínez-Rubio A, Dan GA. Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation?. European Cardiology Review, 2016;11(2):115–7.
    Crossref